Immunomedics Inc said filed registration statement Securities Exchange Commission proposed sale 2,500,000 share common stock .
The company said sell 2,100,000 share certain stockholder sell remaining 400,000 share .
Proceeds offering used product development , basic research , staff expansion , prepayment debt , capital expenditure working capital , company said .
The offering co-managed E.F. Hutton Co Inc First Boston Corp , Immunomedics said .
Reuter & # 3 ; 